Skip to main content

Showing 7051 - 7060 of 8233 results

Caring for the Ages

April 6, 2026

Suzetrigine: A First-in-Class Non-Opioid Analgesic — Promise With Vigilance

Suzetrigine (brand name Journavx) is a recently approved, first-in-class, oral, non-opioid analgesic indicated for the treatment of moderate to severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in 2025, it represents the first novel mechanistic class of oral analgesic in ...